An observational study in Autism Spectrum Disorder (ASD), sponsored by Semmelweis University. Recruiting at 1 site in Hungary. Open to participants aged 18 Months to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Semmelweis University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Autism Spectrum Disorder with a site in Hungary — 3 open to participants now, 3 under way, 1 of them phase 3. Autism Spectrum Disorder · Hungary.
Among the 10 studies in Autism Spectrum Disorder with a site in Hungary, this one is the only one that started in 2025, is the only observational one, and was the 8th registered.
1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.
Browse Autism Spectrum Disorder studies →3 of the 10 studies in Autism Spectrum Disorder with a site in Hungary are open now. Recruiting first, the newest first:
Bristol-Myers Squibb · Sites in Hungary, United States, France and 7 more countries
Ages 5–17
Semmelweis University · Sites in Hungary
Ages 6–12 · Healthy volunteers
A study can be open while its sites in Hungary have not opened yet or have stopped. Only those recruiting at a site in Hungary →
Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.
This study: 18 Months to 6 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 5 · Phase 3 5
First in 2012; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 600 is above the median of 103 across 323 observational studies indexed under Autism Spectrum Disorder.
Median enrollment 211 across the 9 interventional studies, 600 across the 1 observational. Of the 7 that completed or were terminated, 6 (86%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 10 have an industry lead sponsor. The 5 most frequent:
Semmelweis University is the lead sponsor of 140 studies on the registry; 55 are open to participants now.
Semmelweis University has 2 studies filed under Autism Spectrum Disorder — fewer than ten, so there is no comparison to draw.
1 of the studies in Autism Spectrum Disorder with a site in Hungary that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07188870Semmelweis UniversityAssociations of Autistic Traits and Feeding Difficulties | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Autism Spectrum Disorder with a site in Hungary, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objective is to assess the prevalence of autistic traits and feeding disorders in the general population.
The objective of our research is twofold:
I. Firstly, the objective is to assess the prevalence of autistic traits and feeding disorders in the general population. The long-term goal is to develop a widely applicable screening tool for early autism detection that can be widely applied by primary care professionals.
II. Secondly, in the clinical phase of our study, we aim to investigate in greater depth the relationship between feeding difficulties and autism spectrum disorder. In this phase, participants (children in the study group and their parents) will undergo in-person assessments and complete additional questionnaires:
Questionnaires will be made available to parents of Hungarian children between 18 - 72 months, diagnosed with ASD by clinicians involved in their care. Parents of neurotypical or undiagnosed children will be reached through social media platforms and via family pediatricians and health visitors in primary care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
children with BAMBI scores higher than the cut-off
children with BAMBI scores lower than the cut-off
Brief Autism Mealtime Behavior Inventory "BAMBI"scores
Time frame: Cross-sectional study. Through study completion, an average of two years.
Started Jan 2025 (actual). Primary completion is estimated for Dec 2026, 23 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.